Resistance to activated protein C (APC) : influence of factor V levels
Colucci, M.; Ciavarella, N.; Giliberti, M.G.; Semeraro, N.
Thrombosis and Haemostasis 72(6): 987-988
1994
ISSN/ISBN: 0340-6245 PMID: 7740475 Document Number: 426063
Document emailed within 1 workday
Related Documents
Duschek, E.J.J.; Neele, S.J.; Thomassen, M.Christella.L.G.D.; Rosing, J.; Netelenbos, C. 2004: Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 15(8): 649-655Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488
Trossaërt, M.; Conard, J.; Horellou, M.H.; Samama, M.M. 1995: Influence of storage conditions on activated protein C resistance assay Thrombosis and Haemostasis 73(1): 163-164
De Stefano, V.; Leone, G. 1995: Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia Haematologica 80(4): 344-356
Giordano, P.; Sabato, V.; Schettini, F.; De Mattia, D.; Iolascon, A. 1997: Resistance to activated protein C as a risk factor of stroke in a thalassemic patient Haematologica 82(6): 698-700
Leroy-Matheron, C.; Levent, M.; Pignon, J.M.; Mendonça, C.; Gouault-Heilmann, M. 1996: The 1691 G-->A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients Thrombosis and Haemostasis 75(1): 4-10
Levoir, D.; Aubertin, J.M.; Alhenc-Gelas, M.; Bloch, F.; Becheur, H.; Petite, J.P. 1995: A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V Gastroenterologie Clinique et Biologique 19(8-9): 729-731
Rolla, R.; Vidali, M.; Meola, S.; Pollarolo, P.; Pergolini, P.; Bellomo, G. 2011: Estimating the Cost of Redundancy in Molecular Diagnostics: The Case of Activated Protein C Resistance and Factor V Leiden Clinical Laboratory 57(9-10): 711-717
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51
André, E.; Hacquard, M.; Alnot, Y.; de Maistre, E.; Lecompte, T. 2007: Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk? Thrombosis and Haemostasis 98(3): 693-694
Lindqvist, P.G.; Svensson, P.J.; Dahlbäck, B.; Marsál, K. 1998: Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism Thrombosis and Haemostasis 79(1): 69-73
Chan, L.C.; Bourke, C.; Lam, C.K.; Liu, H.W.; Brookes, S.; Jenkins, V.; Pasi, J. 1996: Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene Thrombosis and Haemostasis 75(3): 522-523
Wang, H-ping.; Chen, X-ping.; Ding, L.; He, S-qing.; Ali, M.; Li, D-hua.; Zhang, W-guang. 2003: Hepatitis B x protein activated vascular endothelial growth factor expression through hypoxia inducible factor-1 pathway Zhonghua Zhong Liu Za Zhi 25(5): 433-436
Guichard, G.; Henry, P.C.; Bittard, H.; Kleinclauss, F.ço. 2005: Priapism and activated protein C resistance Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 15(2): 337-338; Discussion 338
Fouéré, S.; Cosnes, A.; Gouault-Heilmann, M.; Revuz, J. 1996: Resistance to activated protein C: a new cause of hypercoagulability Annales de Dermatologie et de Venereologie 123(1): 37-39
Cycowitz, Z.; Seligsohn, U.; Zivelin, A.; Eldor, A. 1995: Resistance to activated protein C--a novel cause of thrombophilia Harefuah 129(1-2): 1-5; 80
Hirai, H.; Shibata, T.; Aoyama, T.; Yoshiyama, M.; Omura, T.; Suehiro, S. 2006: Activation of mitogen-activated protein kinases, activator protein-1, and nuclear factor-kappaB during acute rejection after heterotopic heart transplantation in rats Osaka City Medical Journal 52(1): 9-19
Samama, M.M. 1994: A new cause of hereditary thrombophilia: activated protein c resistance Journal des Maladies Vasculaires 19(3): 173-174
Makris, M.; Bardhan, G.; Preston, F.E. 1996: Warfarin induced skin necrosis associated with activated protein C resistance Thrombosis and Haemostasis 75(3): 523-524
Regéczy, N.; Lakos, G.; Balogh, I.; Kappelmayer, J.; Kiss, E. 2000: Membranous glomerulonephritis in a patient with inherited activated protein C resistance Clinical Nephrology 53(5): 390-393